Actinogen Medical
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Effect of 10 mg Xanamem on Dementia Due to Alzheimer's Disease (NCT06125951) | Actinogen Medical | 2024-04-12 |
| Xanamem® in Adults With Major Depressive Disorder and Impaired Cognition (XanaCIDD) (NCT05657691) | Actinogen Medical | 2022-11-28 |
| A Double-Blind, Placebo-Controlled, Dose Ranging Study of Xanamem® in Healthy Elderly Volunteers (NCT04983368) | Actinogen Medical | 2021-06-30 |
| Xanamem™ in Healthy Elderly Subjects (NCT03830762) | Actinogen Medical | 2019-01-21 |
Track Actinogen Medical automatically
Every clearance here is in the API, with alerts when new ones post.